Will Heineken make a decent return on wine?
New owner of Strongbow hits back at broken deal conditions
Pepkor’s Shop2Shop deal raises eyebrows
iOCO, formerly EOH, is on its way back
Why Competition Commission wants Premier’s RFG deal undone
How to win with delistings deals
Do-over of Premier merger looks like regulatory overkill
Would Campari look to increase its stake in Capevin?
The unprecedented step has rattled Premier shareholders
HeinBev takes on market heavyweight AB InBev
Sanlam’s Santam buyout adds to the exodus
Ultimately, Sanlam wants all of a very good business
Key strategies, tax considerations, and valuations when selling a stake in your business
What’s hot and what’s not in the market
Is Solar's R21.8bn offer for Omnia generous or opportunistic?
Gold Fields needs to flesh out its $27bn bid
Gold Fields keeps Northern Star bid on a tight leash
The share seems undervalued rather than a value trap
Caxton presents an intriguing case for value investors on the JSE
RMB Corvest CEO Mike Donaldson explains why exits are taking longer and how patient capital provides a distinct advantage